Pot, meet Kettle… Big Pharma suing Big Pharma over alleged crafting of exclusive contracts with health insurers and health care providers to keep one drug as a sole treatment option even though the other came out with a cheaper biosimilar version last year. The lawsuit says “consumers suffer in the form of artificially inflated prices.” 🤔Hmmmm, sounds suspiciously familiar…. though this is not over insulin. When blockbuster drugs lose patent protection or face competition from cheaper alternatives, drug companies face the prospect of losing billions of dollars in sales – which still blows my mind since insulin’s patent should have expired by now, leading to generic, cheaper options but the Big 3 Players in the insulin market say they tweak insulin’s formula enough to warrant continued patent protection. It will be interesting to see where this leads. #psychoglycemic #crazyforacure #t1dmom #t1d #insulin4all #insulintolive Instagram filter used: Normal View in Instagram ⇒
